Chemed CHE Net Income Loss Available To Common Stockholders Diluted
Net Income Loss Available To Common Stockholders Diluted at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted.
The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's net income loss available to common stockholders diluted.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's net income loss available to common stockholders diluted?
- Chemed (CHE) reported net income loss available to common stockholders diluted of $66.3M in Q1 2026.
- How has Chemed's net income loss available to common stockholders diluted changed year-over-year?
- Chemed's net income loss available to common stockholders diluted decreased by 7.6% year-over-year, from $71.76M to $66.3M.
- What is the long-term trend for Chemed's net income loss available to common stockholders diluted?
- Over 4 years (2021 to 2025), Chemed's net income loss available to common stockholders diluted has grown at a -0.3% compound annual growth rate (CAGR), from $268.55M to $265.24M.
- What does net income loss available to common stockholders diluted mean?
- The net income attributable to common shareholders after adjusting for the potential dilutive effects of all convertible securities and equity-based awards. This metric provides a conservative view of profitability by accounting for the impact of all potential share issuances. It is the primary figure used to calculate diluted earnings per share.